Department of Gastrointestinal Surgery, Subei People's Hospital of Jiangsu Province (the First Affiliated Hospital of Yangzhou University), Yangzhou 225001, Jiangsu Province, China.
World J Gastroenterol. 2013 Jul 7;19(25):4060-5. doi: 10.3748/wjg.v19.i25.4060.
To investigate the potential impact of complications in gastric cancer patients who survive the initial postoperative period.
Between January 1, 2005 and December 31, 2006, 432 patients who received curative gastrectomy with D2 lymph node dissection for gastric cancer at our department were studied. Associations between clinicopathological factors [age, sex, American Society of Anesthesiologists grade, body mass index, tumor-node-metastases (TNM) stage and tumor grade], including postoperative complications (defined as any deviation from an uneventful postoperative course within 30 d of the operation and survival rates) and treatment-specific factors (blood transfusion, neoadjuvant therapy and duration of surgery). Patients were divided into 2 groups: with (n = 54) or without (n = 378) complications. Survival curves were compared between the groups, and univariate and multivariate models were conducted to identify independent prognostic factors.
Among the 432 patients evaluated, 61 complications occurred affecting 54 patients (12.50%). Complications included anastomotic leakages, gastric motility disorders, anastomotic block, wound infections, intra-abdominal abscesses, infectious diarrhea, bleeding, bowel obstructions, arrhythmias, angina pectoris, pneumonia, atelectasis, thrombosis, unexplained fever, delirium, ocular fungal infection and multiple organ failure. American Society of Anesthesiologists grade, body mass index, combined organ resection and median duration of operation were associated with higher postoperative complications. The 1-, 3- and 5-year survival rates were 83.3%, 53.2% and 37.5%, respectively. In the univariate analysis, the size of lesions, TNM stage, blood transfusion, lymphovascular invasion, perineural invasion, neoadjuvant chemotherapy, and postoperative complications were significant predictors of overall survival. In the multivariate analysis, only TNM stage and the presence of complications remained significant predictors of reduced survival.
The occurrence of in-hospital postoperative complications was an independent predictor of worse 5-year overall survival rate after radical resection of gastric cancer.
探讨胃癌患者术后存活期间发生并发症的潜在影响。
本研究纳入了 2005 年 1 月 1 日至 2006 年 12 月 31 日期间在我科接受根治性胃切除术和 D2 淋巴结清扫术治疗的 432 例胃癌患者。研究了与临床病理因素(年龄、性别、美国麻醉医师协会分级、体重指数、肿瘤-淋巴结-转移分期和肿瘤分级)相关的关联因素,包括术后并发症(定义为手术 30 天内任何偏离无并发症术后过程的情况)和治疗特异性因素(输血、新辅助治疗和手术持续时间)。患者被分为有并发症组(n=54)和无并发症组(n=378)。比较两组的生存曲线,并进行单变量和多变量模型分析以确定独立的预后因素。
在评估的 432 例患者中,54 例(12.50%)发生了 61 种并发症。并发症包括吻合口漏、胃动力障碍、吻合口梗阻、伤口感染、腹腔脓肿、感染性腹泻、出血、肠梗阻、心律失常、心绞痛、肺炎、肺不张、血栓形成、不明原因发热、谵妄、眼部真菌感染和多器官功能衰竭。美国麻醉医师协会分级、体重指数、联合器官切除和手术中位持续时间与较高的术后并发症相关。1、3 和 5 年生存率分别为 83.3%、53.2%和 37.5%。单因素分析显示,病变大小、TNM 分期、输血、脉管侵犯、神经侵犯、新辅助化疗和术后并发症是总生存的显著预测因素。多因素分析显示,只有 TNM 分期和并发症的存在是降低生存的显著预测因素。
根治性胃切除术后住院期间发生术后并发症是总生存 5 年率降低的独立预测因素。